XUXIN (HONGKONG) BIOTECHNOLOGY CO., LIMITEDHong Kong SAR or China On-site Full Time 3 - 30 Year Mid-Senior level Skills: Communication, Dependability, Problem-solving Responsibilities of Nucleic Acid Chemistry Scientist Position: Achieve patent breakthroughs in side chain modification and delivery systems for small nucleic acid innovative drug projects, and conduct purposeful, strategic drug molecular design aligned with the characteristics of small nucleic acid therapeutics. Optimize lead compounds through systematic analysis of efficacy, pharmacokinetic, and safety data to confirm preclinical candidate compounds within established timelines. Strategically develop and file patents related to chemical modifications and delivery systems, establishing a comprehensive intellectual property (IP) protection framework for associated programs. Manage collaborations with CROs and CDMOs for chemical synthesis, purification, analytical testing, quality control, and monitor vendor progress to ensure compound quality. Requirements: Master’s or Ph D degree in Chemistry, Analytical Chemistry, or a related discipline. Minimum 3 years of industry experience in relevant fields; hands-on experience in small nucleic acid modifications and delivery systems is highly preferred. Strong literature review and scientific writing skills, with the ability to independently search and analyze domestic/international patents, technical publications, and regulatory guidelines. Detail-oriented, self-motivated, and responsible with a positive attitude; excellent communication and organizational skills to collaborate cross-functionally. Job Level Mid-Senior level Publish Date07/03/2025 Job Ref. No. N/AJob Function Biotechnology, Life Science Company Overview XUXIN (Hong Kong) Biotechnology Co., Limited is a wholly-owned subsidiary established in Hong Kong in 2024 by Reco RNA (Guangzhou) Biotechnology Co., Ltd. The company was founded by a team of scientists led by a Stanford University-trained Ph. D. and senior pharmaceutical executives with extensive experience in managing international and domestic pharmaceutical companies. XUXIN focuses on AI-driven innovative RNA drug development for addressing unmet clinical needs in the treatment of genetic diseases, neurological disorders, and chronic illnesses. #J-18808-Ljbffr